US Stock MarketDetailed Quotes
EXAS Exact Sciences
- 63.240
- -0.290-0.46%
Close Apr 24 16:00 ET
- 63.130
- -0.110-0.17%
Post 16:30 ET
11.48BMarket Cap-55964P/E (TTM)
64.280High63.220Low1.21MVolume63.540Open63.530Pre Close77.13MTurnover0.68%Turnover RatioLossP/E (Static)181.53MShares100.77052wk High3.65P/B11.36BFloat Cap56.05052wk Low--Dividend TTM179.56MShs Float159.540Historical High--Div YieldTTM1.67%Amplitude0.220Historical Low63.552Avg Price1Lot Size
About Exact Sciences Company
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Company Profile
SymbolEXAS
Company NameExact Sciences
Listing DateJan 31, 2001
Issue Price14.00
Founded1995
CEOMr. Kevin T. Conroy
MarketNASDAQ
Employees6600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5505 Endeavor Lane
CityMadison
ProvinceWisconsin
CountryUnited States of America
Zip Code53719
Phone1-608-284-5700
Websitehttp://www.exactsciences.com
Company Executives
- Name
- Position
- Salary
- Kevin T. Conroy
- Chairman of the Board, President and Chief Executive Officer
- 14.22M
- Jeffrey T. Elliott
- Executive Vice President, Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer
- 3.87M
- Everett V. Cunningham
- Chief Commercial Officer
- 5.18M
- Brian Baranick
- General Manager, Precision Oncology
- --
- Jake Orville
- General Manager, Screening
- 2.75M
- Aaron Bloomer
- Executive Vice President, Finance
- --
- Sarah Condella
- Executive Vice President, Human Resources
- 2.71M
- James Herriott
- Senior Vice President, General Counsel and Secretary
- --
- Scott D. Coward
- Director
- 5.07M
- Timothy John Scannell
- Director
- --
- Shacey Petrovic
- Independent Director
- 324.97K
- Daniel Joseph Levangie
- Independent Director
- 332.47K
- Kathleen Sebelius
- Independent Director
- 335.47K
- Dr. Freda C. Lewis-Hall,M.D.
- Independent Director
- 326.47K
- Pierre Jacquet
- Independent Director
- 322.97K
- Paul J. Clancy
- Independent Director
- 341.47K
- James E. Doyle
- Lead Independent Director
- 356.47K
- Katherine S. Zanotti
- Independent Director
- 329.97K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
